Breaking News

EUROAPI Reports Progressive Restart of Prostaglandin Production

Majority of production at the Budapest site expected to be back online by mid-April 2023.

By: Tim Wright

Editor, Contract Pharma

EUROAPI progressively restarted prostaglandin production at its Budapest site on January 19, 2023.

As first reported in its press release of December 7, 2022, EUROAPI identified certain Good Manufacturing Practices deficiencies related to production documentation during an internal assessment and decided to temporarily suspend prostaglandin activities at its Budapest site.

The company said it has built and implemented a remediation plan, allowing to progressively restart prostaglandin production in January. As the restart is progressive in nature by design, EUROAPI expects the majority of prostaglandin production to be back online by mid-April 2023.

As anticipated, no other activities at the Budapest site were impacted, including contract development and manufacturing organization (CDMO) activities.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters